U.S. Doubles Down On Pfizer Branded Treatments

I fully recovered from Covid-19 with zero treatment.

The interesting thing is that about 4-5 days after getting better I contracted a common cold type virus, and that was actually worse than having Covid.

That being said, this virus is really not that big of a deal, and if it truly was then potentially life saving medication like Ivermectin would not be suppressed by a global superpower.

The oligarchy in The U.S. has decided to double down on its purchase of Pfizer branded treatments to combat Covid-19 instead of simply allowing these potentially life saving treatments, and promoting healthy diet and exercise.

Healthy Vitamin intake would also be a wonderful recommendation, but again over the course of the last two years we have not seen the federal government promote this incredibly powerful preventative health care measure.

Recent reports indicate that the federal government has ordered another 10 million rounds of Pfizer’s drug Paxlovid—a pill intended to treat Covid-19.

Keep in mind that Pfizer’s stock is one of the most widely held stocks by U.S. Congress members…

Here’s more on the story:

🆕 NIH Guidelines for COVID-19 Treatment in High-Risk Patients (including immunocompromised) in the Outpatient Setting

Outpatient Rx Recommendations:
1️⃣ Paxlovid PO
2️⃣ Sotrovimab IV
3️⃣ Remdesivir IV
4️⃣ Molnupiravir PO#RheumTwitter #IDTwitter #Omicron pic.twitter.com/ke8uLMvxvT

— Mithu Maheswaranathan, MD (@MithuRheum) January 5, 2022

https://twitter.com/CryanGrim/status/1478616768050466816

10 million more doses were ordered by the government according to The Hill:

The United States is purchasing an additional 10 million courses of Pfizer’s COVID-19 treatment Paxlovid, the company said Tuesday, bringing the total U.S. order to 20 million.

The move comes as the Biden administration seeks to ramp up the treatments available as another tool to battle the virus.

We need to draw a line in the sand. The risk of this medication does not outweigh the benefit – especially with Paxlovid EUA done. There needs to be a global moratorium on this medication as it could kill us all. One bad variant is all it takes. https://t.co/arKJjhf5xs

— Doc T MD/PhD (@lewistlc) December 31, 2021

why pharma do well?? everyone say good short, never able bring drug to market, R&D slow and inefficient only bring Paxlovid and vax -> super bad drug and super slow development!!!!!????? pic.twitter.com/9pwX8MuaAq

— Dennis Gong (@GongDennis) January 5, 2022

The Guardian asks why this treatment will only be available to a select few:

That gets us to the vital need for the Paxlovid five-day pill pack (two pills a day, and one other pill, a low dose ritonavir to help raise Paxlovid’s blood level) to be available everywhere.

BOOKMARK IT: Check Out My New Site, NoahReport.com!

But there is a grossly insufficient supply of only 200,000 treatment courses now, and only 80 million expected by the end of next year.

If we had an unlimited supply of these pills, it could have an extraordinary impact on preventing illness, preserving our healthcare workforce, staving off spread, eliminating the need for lockdowns and school closings.

Paxlovid intervention might also reduce the toll of long Covid, a disabling symptom complex that can occur with even mild cases.